$8.09
Price
$462M
Market Cap
—
P/E Ratio
-2.3
Forward P/E
$-3.75
EPS (TTM)
—
Dividend Yield
$305M
Cash
$25M
Total Debt
57M
Shares Out
$2.23
$12.34
52-Week Range
Institutional Ownership of 4D MOLECULAR THERAPEUTICS IN
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for 4D MOLECULAR THERAPEUTICS IN
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q3 | |||||
| SELL | EXIT | — | — | $15.51 | |
| 2024-Q1 | |||||
| SELL | -38.7% | 2.9M | $94M | $27.39 | |
| 2023-Q2 | |||||
| BUY | +21.6% | 4.8M | $87M | $18.06 | |
| 2020-Q4 | |||||
| BUY | NEW | 3.9M | $163M | $40.50 | |
Insider Trading for 4D MOLECULAR THERAPEUTICS IN
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.